Prompt Lispro Fin review: two public narratives describe different services

Prompt Lispro Fin appears in public narratives with different descriptions of its role. That is a more useful finding than treating repeated branding as corroboration of one platform or launch.

What the available sources show

The modelexorex-100.com page, captured on 21 September 2026, describes AI-assisted trading and funding from INR 21,000. The modelexorex100.net about page instead emphasizes decision support and reviewable data, while saying it does not provide personalized financial advice. No common ownership, shared account or history connecting the sites was authenticated. The money figure belongs to the first presentation, not both.

Reading the claim carefully

The second site describes a mission around visible assumptions and records. That is a statement of positioning, not proof that the records were supplied or audited. The first site’s registration sequence likewise describes an intended process, not a customer journey we observed reaching a funded account.

Conditions and conclusion

An announcement about analysis and one about trade execution should identify who performs each activity before they can be read as the same offer. Ask which domain supplies the proposed account and which agreement applies. The published descriptions do not validate a performance record, customer total or successful funding process. Our verdict is unknown, with no account opened or withdrawal tested. There are two attributable website narratives to compare, but insufficient evidence to report one verified operating service or to endorse its advertised capabilities.